FdaApplication
ANDA 090825
Identifiers
- fda_app_no: ANDA090825
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | ANDA |
| approval_date | 2011-11-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMIPENEM AND CILASTATIN | CILASTATIN SODIUM; IMIPENEM | EQ 250MG BASE/VIAL;250MG/VIAL | POWDER;INTRAVENOUS |
| IMIPENEM AND CILASTATIN | CILASTATIN SODIUM; IMIPENEM | EQ 500MG BASE/VIAL;500MG/VIAL | POWDER;INTRAVENOUS |
2 products